1 – 4 of 4
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Hormone receptor mRNA and protein levels as predictors of premenopausal tamoxifen benefit
Engström, Terese ; Ekholm, Maria ; Fernö, Mårten LU ; Lundgren, Christine LU ; Nordenskjöld, Bo ; Stål, Olle ; Bendahl, Pär Ola LU ; Tutzauer, Julia LU
and Rydén, Lisa
LU
(2024)
In Acta Oncologica
63.
p.125-136
- Contribution to journal › Article
- 2023
-
Mark
Tamoxifen-predictive value of gene expression signatures in premenopausal breast cancer : data from the randomized SBII:2 trial
Lundgren, Christine LU ; Tutzauer, Julia LU
; Church, Sarah E.
; Stål, Olle
; Ekholm, Maria
LU
; Forsare, Carina
LU
; Nordenskjöld, Bo
; Fernö, Mårten
LU
; Bendahl, Pär Ola
LU
and Rydén, Lisa
LU
(2023)
In Breast Cancer Research
25(1).
- Contribution to journal › Article
- 2022
-
Mark
Breast cancer hypoxia in relation to prognosis and benefit from radiotherapy after breast-conserving surgery in a large, randomised trial with long-term follow-up
Tutzauer, Julia LU
; Sjöström, Martin
LU
; Holmberg, Erik
; Karlsson, Per
; Killander, Fredrika
LU
; Leeb-Lundberg, L M Fredrik
LU
; Malmström, Per
LU
; Niméus, Emma
LU
; Fernö, Mårten
LU
and Jögi, Annika
LU
(2022)
In British Journal of Cancer
126(8).
p.1145-1156
- Contribution to journal › Article
- 2020
-
Mark
Plasma membrane expression of G protein-coupled estrogen receptor (GPER)/G protein-coupled receptor 30 (GPR30) is associated with worse outcome in metachronous contralateral breast cancer
Tutzauer, Julia LU
; Sjöström, Martin
LU
; Bendahl, Pär Ola
LU
; Rydén, Lisa
LU
; Fernö, Mårten
LU
; Fredrik Leeb-Lundberg, L. M.
LU
and Alkner, Sara
LU
(2020)
In PLoS ONE
15(4).
- Contribution to journal › Article